• 1
    Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11-30.
  • 2
    Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2010. Bethesda, MD: National Cancer Institute. Based on November 2012 SEER data submission, posted to the SEER web site, April 2013.
  • 3
    American Cancer Society. Cancer Facts & Figures 2013. Atlanta, GA: American Cancer Society; 2013.
  • 4
    Murphy CC, Bartholomew LK, Carpentier MY, Bluethmann SM, Vernon, SW. Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review. Breast Cancer Res Treat. 2012;134:459-478.
  • 5
    Khatcheressian JL, Hurley P, Bantug E, et al; American Society of Clinical Oncology. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31:961-965.
  • 6
    National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Breast Cancer, Version 3.2013. National Comprehensive Cancer Network. Accessed May 30, 2013.
  • 7
    Keating NL, Landrum MB, Guadagnoli E, Winer, EP, Ayanian JZ. Factors related to underuse of surveillance mammography among breast cancer survivors. J Clin Oncol. 2006;24:85-94.
  • 8
    Doubeni CA, Field TS, Ulcickas Yood M, et al. Patterns and predictors of mammography utilization among breast cancer survivors. Cancer. 2006;106:2482-2488.
  • 9
    Field TS, Doubeni C, Fox MP, et al. Underutilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med. 2007;23:158-163.
  • 10
    Carcaise-Edinboro P, Bradley CJ, Dahman B. Surveillance mammography for Medicaid/Medicare breast cancer patients. J Cancer Surviv. 2010;4:59-66.
  • 11
    Sabatino SA, Thompson TD, Richardson LC, Miller J. Health insurance and other factors associated with mammography surveillance among breast cancer survivors. Med Care. 2012;50:270-276.
  • 12
    Breslau ES, Jeffery DD, Davis WW, Moser RP, McNeel TS, Hawley S. Cancer screening practices among racially and ethnically diverse breast cancer survivors: results from the 2001 and 2003 California Health Interview Survey. J Cancer Surviv. 2010;4:1-14.
  • 13
    Shelby RA, Scipio CD, Somers TJ, Soo MS, Weinfurt KP, Keefe FJ. Prospective study of factors predicting adherence to surveillance mammography in women treated for breast cancer. J Clin Oncol. 2012;30:813-819.
  • 14
    Menashe I, Anderson WF, Jatoi I, Rosenberg PS. Underlying causes of the black–white racial disparity in breast cancer mortality: a population-based analysis. J Natl Cancer Inst. 2009;101:993-1000.
  • 15
    Fleming ID, Cooper JS, Henson DE, et al. AJCC Cancer Staging Manual. 5th ed. Philadelphia, PA: Lippincott-Raven; 1997.
  • 16
    Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002.
  • 17
    Litton JK, Gonzalez-Angulo AM, Warneke CL, et al. Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. J Clin Oncol. 2008;26:4072-4077.
  • 18
    Houston, Sugar Land, Baytown Metro Area. Based on US 2010 data. Accessed 2013.
  • 19
    Janz NK, Hawley ST, Mujahid MS, et al. Correlates of worry about recurrence in a multiethnic population-based sample of women with breast cancer. Cancer. 2011;117:1827-1836.
  • 20
    Chatman MC, Green RD. Addressing the unique psychosocial barriers to breast cancer treatment experienced by African-American women through integrative navigation. J Natl Black Nurs Assoc. 2011;22:20-28.
  • 21
    Rust C, Davis C. Health literacy and medication adherence in underserved African-American breast cancer survivors: a qualitative study. Soc Work Health Care. 2011;50:739-761.
  • 22
    Ashing-Giwa KT, Lim J. Examining the impact of socioeconomic status and socioecologic stress on physical and mental health quality of life among breast cancer survivors. Oncol Nurs Forum. 2009;36:79-88.
  • 23
    Darby K, Davis C, Likes W, Bell J. Exploring the financial impact of breast cancer for African American medically underserved women: a qualitative study. J Health Care Poor Underserved. 2009;20:721-728.
  • 24
    Payne S, Jarrett N, Jeffs D. The impact of travel on cancer patients' experiences of treatment: a literature review. Eur J Cancer Care. 2008;9:197-203.
  • 25
    Crawford MS, Sauerzapf V, Haynes R, Forman D, Jones AP. Social and geographical factors affecting access to treatment of colorectal cancer: a cancer registry study. BMJ Open. 2012;2:1-6.
  • 26
    Holmes J, Carpenter WR, Wu Y, et al. Impact of distance to a urologist on early diagnosis of prostate cancer among black and white patients. J Urol. 2012;187:883-888.
  • 27
    Mao JJ, Bowman MA, Stricker CT, et al. Delivery of survivorship care by primary care physicians: the perspective of breast cancer patients. J Clin Oncol. 2009;27:933-938.
  • 28
    Cheung WY, Aziz N, Noone AM, et al. Physician preferences and attitudes regarding different models of cancer survivorship care: a comparison of primary care providers and oncologists. J Cancer Surviv. 2013;7:343-354.
  • 29
    Virgo KS, Lerro CC, Klabunde CN, Earle C, Ganz PA. Barriers to breast and colorectal cancer survivorship care: perceptions of primary care physicians and medical oncologists in the United States. J Clin Oncol. 2013;31:2322-2336.
  • 30
    Makubate B, Donnan PT, Dewar JA, Thompson AM, McCowan C. Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality. Br J Cancer. 2013;108:1515-1524.
  • 31
    Hershman DL, Kushi LH, Shao T, et al. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol. 2010;28:4120-4128.
  • 32
    Kimman ML, Bloebaum MM, Dirksen CD, Houben RM, Lambin P, Boersma LJ. Patient satisfaction with nurse-led telephone follow-up after curative treatment for breast cancer. BMC Cancer. 2010;10:1-10.
  • 33
    Sheppard C, Higgins B, Wise M, Yiangou C, Dubois D, Kilburn S. Breast cancer follow up: a randomised controlled trial comparing point of need access versus routine 6-monthly clinical review. Eur J Oncol Nurs. 2009;13:2-8.
  • 34
    Beaver K, Tysver-Robinson D, Campbell M, et al. Comparing hospital and telephone follow-up after treatment for breast cancer: randomized equivalence trial. Br Med J. 2009;338:a3147.
  • 35
    Ruiz JM, Steffen P, Smith TB. Hispanic mortality paradox: a systematic review and meta-analysis of the longitudinal literature. Am J Public Health. 2013;103:e52-e60.
  • 36
    Borrell LN, Lancet EA. Race/ethnicity and all-cause mortality in US adults: revisiting the Hispanic paradox. Am J Public Health. 2012;102:836-843.
  • 37
    Newman LA, Mason J, Cote D, et al. African-American ethnicity, socioeconomic status, and breast cancer survival. A meta-analysis of 14 studies involving over 10,000 African-American and 40,000 white American patients with carcinoma of the breast. Cancer. 2002;94:2844-2854.
  • 38
    Gerend MA, Pai M. Social determinants of black-white disparities in breast cancer mortality: a review. Cancer Epidemiol Biomarkers Prev. 2008;17:2913-2923.
  • 39
    Tannenbaum SL, Koru-Sengul T, Miao F. Disparities in survival after female breast cancer diagnosis: a population-based study. Cancer Causes Control. 2013;24:1705-1715.
  • 40
    Ashing-Giwa KT, Padilla G, Tejero J, et al. Understanding the breast cancer experience of women: a qualitative study of African American, Asian American, Latina and Caucasian cancer survivors. Psychooncology. 2004;13:408-428.
  • 41
    Lim JW, Gonzalez P, Wang-Letzkus MF, Ashing-Giwa KT. Understanding the cultural health belief model influencing health behaviors and health-related quality of life between Latina and Asian-American breast cancer survivors. Supportive Care Cancer. 2009;17:1137-1147.
  • 42
    Grunfeld EA, Hunter MS, Sikka P, Mittala S. Adherence beliefs among breast cancer patients taking tamoxifen. Patient Educ Couns. 2005;59:97-102.
  • 43
    Doggrell SA. Adherence to oral endocrine treatments in women with breast cancer: can it be improved? Breast Cancer Res Treat. 2011;129:299-308.
  • 44
    Ruddy K, Mayer E, Partridge A. Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin. 2009;59:56-66.
  • 45
    Owusu C, Buist DS, Field TS, et al. Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer. J Clin Oncol. 2008;26:549-555.
  • 46
    Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA. 2005;294:1765-1772.
  • 47
    Edelman MJ, Meyers FJ, Siegel D. The utility of follow-up testing after curative cancer therapy. A critical review and economic analysis. J Gen Intern Med. 1997;12:318-331.
  • 48
    Smith TJ, Davidson NE, Schapira DV, et al. American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol. 1999;17:1080-1082.